Eutilex
Seoul
About Eutilex
Eutilex Co., Ltd. develops biotechnology. The Company develops immunotherapy technology, anti tumor T cell therapy and antibody therapeutics, and other technology products. Eutilex markets its products throughout South Korea.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 51 – 100
- Estimated revenue: Less than $1M
- Total funding: $18.1M
- Funding stage: Early Stage Venture
- Last round: Series A (Dec 2016)
- Website: eutilex.com
Industries & Categories
Biopharma, Biotechnology, Medical
Social Profiles
Canonical: https://fsome.com/organization/eutilex-151998 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.